Actively Recruiting
Evaluating Anti-CD19 CAR T-Cell Therapy for Severe Systemic Sclerosis Resistant to Immunosuppressive Drugs in Adults
Led by University Hospital, Montpellier · Updated on 2026-10-14
6
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate whether anti-CD19 CAR T-cell therapy can reduce disease activity in adults with severe systemic sclerosis SSc that has not responded to standard immunosuppressive treatments. Systemic sclerosis is a serious autoimmune disease causing skin and organ fibrosis, blood vessel problems, and immune system issues. The study is a Phase IIa, multicenter, single-arm trial designed to assess the feasibility, safety, and initial clinical effects of this therapy in patients resistant to usual medications. Participants will first undergo leukapheresis to collect T cells, which are then modified in a specialized facility to create anti-CD19 CAR T-cells. Before receiving the CAR T-cells, they will get a short course of lymphodepleting chemotherapy. On Day 0, participants will be infused once intravenously with the CAR T-cells and stay in the hospital for about 10 days for close monitoring. After discharge, they will attend follow-up visits for up to 24 months, including clinical exams, blood tests, organ function assessments, and optional skin or lymph-node biopsies. During the study, researchers will monitor the behavior and persistence of CAR T-cells in the body, measure changes in skin thickening using the modified Rodnan skin score, and assess disease activity with various clinical and biological tests. Safety will be closely tracked throughout, including potential side effects such as cytokine release syndrome or neurotoxicity. Participants will have regular assessments and imaging to evaluate organ health and overall disease progression over two years.
CONDITIONS
Brief Title
Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy
Research Team
C
Charlotte KAAN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here